
Peter Paras Jr.
Supervisory Patent Examiner (ID: 10504, Phone: (571)272-4517 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632, 1635 |
| Total Applications | 422 |
| Issued Applications | 86 |
| Pending Applications | 232 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17733384
[patent_doc_number] => 20220218843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA
[patent_app_type] => utility
[patent_app_number] => 17/267482
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267482 | NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA | Oct 29, 2018 | Abandoned |
Array
(
[id] => 13982485
[patent_doc_number] => 20190060400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => USE OF DESIGNER RECEPTORS EXCLUSIVELY ACTIVATED BY DESIGNER DRUGS AND ULTRASOUND IN THE TREATMENT OF SEIZURE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/921906
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15921906
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/921906 | USE OF DESIGNER RECEPTORS EXCLUSIVELY ACTIVATED BY DESIGNER DRUGS AND ULTRASOUND IN THE TREATMENT OF SEIZURE DISORDERS | Mar 14, 2018 | Abandoned |
Array
(
[id] => 16808232
[patent_doc_number] => 20210130785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => MEDIUM FOR INDUCING DIFFERENTIATION OF STEM CELLS INTO MESODERMAL CELLS AND METHOD FOR PRODUCING MESODERMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/480670
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480670
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480670 | MEDIUM FOR INDUCING DIFFERENTIATION OF STEM CELLS INTO MESODERMAL CELLS AND METHOD FOR PRODUCING MESODERMAL CELLS | Jan 24, 2018 | Abandoned |
Array
(
[id] => 17679583
[patent_doc_number] => 11363812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Cell freezing medium for clinical use
[patent_app_type] => utility
[patent_app_number] => 16/472962
[patent_app_country] => US
[patent_app_date] => 2017-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 3844
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472962 | Cell freezing medium for clinical use | Dec 24, 2017 | Issued |
Array
(
[id] => 16598362
[patent_doc_number] => 20210024893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => MEDICAL USES OF EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/341793
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341793 | MEDICAL USES OF EXOSOMES | Oct 11, 2017 | Abandoned |
Array
(
[id] => 14338769
[patent_doc_number] => 20190151357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => MATERIALS AND METHODS FOR PRODUCING AND USING MITOCHONDRIAL PREPARATIONS
[patent_app_type] => utility
[patent_app_number] => 16/321317
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321317
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321317 | MATERIALS AND METHODS FOR PRODUCING AND USING MITOCHONDRIAL PREPARATIONS | Sep 10, 2017 | Abandoned |
Array
(
[id] => 17695939
[patent_doc_number] => 11369641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Identification and uses of vasculature forming progenitor cells and progenitor cell combinations
[patent_app_type] => utility
[patent_app_number] => 16/323079
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 49
[patent_no_of_words] => 13878
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323079
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323079 | Identification and uses of vasculature forming progenitor cells and progenitor cell combinations | Aug 24, 2017 | Issued |
Array
(
[id] => 17200400
[patent_doc_number] => 20210340495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => METHOD FOR INDUCING AND DIFFERENTIATING PLURIPOTENT STEM CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/322640
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322640
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322640 | METHOD FOR INDUCING AND DIFFERENTIATING PLURIPOTENT STEM CELLS AND USES THEREOF | Jul 26, 2017 | Abandoned |
Array
(
[id] => 12051500
[patent_doc_number] => 20170327844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'OPTIMIZATION OF DETERMINANTS FOR SUCCESSFUL GENETIC CORRECTION OF DISEASES, MEDIATED BY HEMATOPOIETIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/603510
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 51600
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/603510 | OPTIMIZATION OF DETERMINANTS FOR SUCCESSFUL GENETIC CORRECTION OF DISEASES, MEDIATED BY HEMATOPOIETIC STEM CELLS | May 23, 2017 | Abandoned |
Array
(
[id] => 12051500
[patent_doc_number] => 20170327844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'OPTIMIZATION OF DETERMINANTS FOR SUCCESSFUL GENETIC CORRECTION OF DISEASES, MEDIATED BY HEMATOPOIETIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/603510
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 51600
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/603510 | OPTIMIZATION OF DETERMINANTS FOR SUCCESSFUL GENETIC CORRECTION OF DISEASES, MEDIATED BY HEMATOPOIETIC STEM CELLS | May 23, 2017 | Abandoned |
Array
(
[id] => 14273769
[patent_doc_number] => 20190134169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => DLL4-expressing cells and vaccine using the same
[patent_app_type] => utility
[patent_app_number] => 16/095986
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095986 | DLL4-expressing cells and vaccine using the same | Apr 25, 2017 | Abandoned |
Array
(
[id] => 15681775
[patent_doc_number] => 20200095551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => METHODS, SYSTEMS, FACTORS, AND MEDIA FOR REDUCTION OF CELLULAR STRESS AND REACTIVE OXYGEN SPECIES
[patent_app_type] => utility
[patent_app_number] => 16/494662
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494662
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494662 | METHODS, SYSTEMS, FACTORS, AND MEDIA FOR REDUCTION OF CELLULAR STRESS AND REACTIVE OXYGEN SPECIES | Mar 16, 2017 | Abandoned |
Array
(
[id] => 13397697
[patent_doc_number] => 20180250391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 15/760726
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760726
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760726 | COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE | Sep 15, 2016 | Abandoned |
Array
(
[id] => 15345925
[patent_doc_number] => 20200010854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => CRISPR/CAS9-BASED TREATMENTS
[patent_app_type] => utility
[patent_app_number] => 15/741444
[patent_app_country] => US
[patent_app_date] => 2016-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741444
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741444 | CRISPR/CAS9-BASED TREATMENTS | Jul 4, 2016 | Abandoned |
Array
(
[id] => 10939431
[patent_doc_number] => 20140342452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'Islet Cells From Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 14/315204
[patent_app_country] => US
[patent_app_date] => 2014-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13736
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315204
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/315204 | Islet Cells From Human Embryonic Stem Cells | Jun 24, 2014 | Abandoned |
Array
(
[id] => 9383987
[patent_doc_number] => 20140087469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'SYSTEM AND PROCESS FOR GENETIC AND EPIGENETIC TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/096935
[patent_app_country] => US
[patent_app_date] => 2013-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8707
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14096935
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/096935 | SYSTEM AND PROCESS FOR GENETIC AND EPIGENETIC TREATMENT | Dec 3, 2013 | Abandoned |
Array
(
[id] => 9477258
[patent_doc_number] => 20140134721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'Chondrocyte Precursors Derived From Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 14/015040
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8002
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14015040
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/015040 | Chondrocyte Precursors Derived From Human Embryonic Stem Cells | Aug 29, 2013 | Abandoned |
Array
(
[id] => 9093695
[patent_doc_number] => 20130273006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/888748
[patent_app_country] => US
[patent_app_date] => 2013-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 31206
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13888748
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/888748 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS | May 6, 2013 | Abandoned |
Array
(
[id] => 10298850
[patent_doc_number] => 20150183850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS'
[patent_app_type] => utility
[patent_app_number] => 14/402064
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 21880
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402064
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402064 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS | Mar 13, 2013 | Abandoned |
Array
(
[id] => 10947066
[patent_doc_number] => 20140350087
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2014-11-27
[patent_title] => 'Oncovector Nucleic Acid Molecules and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/801940
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 80619
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801940
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/801940 | Oncovector Nucleic Acid Molecules and Methods of Use | Mar 12, 2013 | Abandoned |